ArticleAdvances in hematology2011
Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.
Article in Advances in hematology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 51 citations in OpenAlex.
- Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma.JCO clinical cancer informatics · 2024Article
- Urinary Metabolic Distinction of Niemann-Pick Class 1 Disease through the Use of Subgroup Discovery.Metabolites · 2023Article
- Primary hepatic Hodgkin's lymphoma: A case report.Journal of family medicine and primary care · 2022Article
- Extracellular vesicle: A magic lamp to treat skin aging, refractory wound, and pigmented dermatosis?Frontiers in bioengineering and biotechnology · 2022Review
- Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma.Journal of assisted reproduction and genetics · 2020Article
- Methodological framework for radiomics applications in Hodgkin's lymphoma.European journal of hybrid imaging · 2020Article
- Phytochemical profile and antioxidation activity of annona fruit and its effect on lymphoma cell proliferation.Food science & nutrition · 2020Article
- Hodgkin lymphoma presenting as alcohol-induced back pain.BMJ case reports · 2019Article
- Abdominal Lymphocyte-Depleted Hodgkin Lymphoma: A Rare Presentation.International journal of general medicine · 2019Article
- Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.Seminars in oncology · 2017Article
- Lymphocyte Depleted Hodgkin's Lymphoma Presented with Haemolytic Anemia: A Case Report and Literature Review.Journal of maxillofacial and oral surgery · 2015Article
- Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus.The Indian journal of medical research · 2014Article
- Customized targeted therapy in Hodgkin lymphoma: hype or hope?Hematology/oncology clinics of North America · 2014Review
- Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.Cellular and molecular neurobiology · 2013Review
- Review
- Recognizing unusual manifestations of Hodgkin lymphoma.Current hematologic malignancy reports · 2012Review
- Circulating microRNAs involved in multiple sclerosis.Molecular biology reports · 2012Article
- Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphoma.The oncologist · 2012Article
- Pelvic lymphoma: An unusual presentation.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2011Article
- Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances.Genome medicine · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
From its first description by Thomas Hodgkin in 1832, Hodgkin's disease, now called Hodgkin's lymphoma, has continued to be a fascinating neoplasm even to this day. In this review, historical aspects, epidemiology, diagnosis, tumor biology, new observations related to host-microenvironment interactions, gene copy number variation, and gene expression profiling in this complex neoplasm are described, with an exploration of chemoresistance mechanisms and potential novel therapies for refractory disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.